Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines

Overview of attention for article published in BMC Medicine, December 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 44 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 15,360 followers.

RT @maasvdn: Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison betwe…

14 May 2019

Reply Repost Favourite

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines https://t.co/d8I9pWrJII

13 May 2019

Reply Repost Favourite

Para leer sobre la costo-efectividad de la vacunación contra el herpes zoster en adultos mayores inmunocompetentes pueden consultar el siguiente enlace: https://t.co/684L9gzEm8

27 Dec 2018

Reply Repost Favourite

Published this week in @BMCMedicine : Cost-effectiveness of #vaccination of immunocompetent older adults against #herpes zoster in the #Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines @rivm https://t.co/OA9C5I4lQQ

07 Dec 2018

Reply Repost Favourite

New research today! Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines https://t.co/OA9C5I4lQQ @rivm @univgroningen

06 Dec 2018

Reply Repost Favourite